Cancer organoid Growth Kit

Cell proliferation and cytotoxicity assay kit for evaluating cell viability and drug efficacy in research and drug development. Provides quantitative measurement of live and dead cells, enabling assessment of compound toxicity and cellular response in laboratory settings.

Custom organoid cultures developed from individual patient tumor samples for personalized medicine applications, drug sensitivity testing, and treatment planning in oncology.

A three-dimensional in vitro cell culture system that establishes patient-derived tumor organoid models highly similar to patient tumor characteristics. The tumor organoids maintain high consistency with patient tumor pathological, molecular, and genetic features while enabling personalized drug sensitivity assessment, with reported accuracy up to 80%.

Organ-on-chip microfluidic devices that model human tissue and organ function in vitro for drug testing, toxicology, and disease research. These bioengineered chips integrate multiple cell types in physiologically relevant configurations, enabling predictive evaluation of therapeutic efficacy and safety. Applications include pharmaceutical development, personalized medicine, and reduction of animal testing in preclinical studies.

Specialized microfluidic organ-on-chip platforms for in vitro tissue modeling and drug testing in biomedical research.

Advanced microfluidic organ-on-a-chip devices that model human organ functions for drug testing and disease research. These systems provide realistic biological microenvironments for preclinical evaluation of therapeutics.

A microfluidic-based system for creating and studying organ-like tissue structures in vitro. It enables advanced cell culture, perfusion, and multi-reagent delivery for studying organ function and drug responses.

An integrated organoid-based system for preclinical drug screening and development, enabling pharmaceutical companies to test compound efficacy on relevant tissue models.

A comprehensive organoid culture and development platform designed for creating three-dimensional tissue models from patient or donor cells. The system supports the establishment and maintenance of organoid biobanks for research and therapeutic applications.

Specialized organoid systems designed for tissue regeneration research, including organ-specific models for studying developmental biology and therapeutic regeneration strategies.

Accurate International Biotechnology provides a comprehensive organoid full lifecycle technology platform for drug development and research. The platform offers high-efficiency screening, precise prediction, controlled risk management, and cost-saving solutions for pharmaceutical enterprises conducting CRO technical services.

Microfluidic platforms designed for high-throughput organoid, spheroid and organ-on-chip culturing and analysis. These systems enable controlled environments for advanced biological research and drug development.